{"id":71489,"date":"2026-05-20T10:10:00","date_gmt":"2026-05-20T10:10:00","guid":{"rendered":"https:\/\/medsbase.com\/slu-pp-332\/"},"modified":"2026-05-21T07:14:09","modified_gmt":"2026-05-21T07:14:09","slug":"slu-pp-332","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/slu-pp-332\/","title":{"rendered":"SLU-PP-332 (Pan-ERR Agonist Mimetic al Exerci\u021biului)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u0103spuns rapid \u2014 Ce este SLU-PP-332?<\/h3>\n<p style=\"margin: 0;\"><strong>SLU-PP-332<\/strong> (CAS 303760-60-3, MF C<sub>18<\/sub>H<sub>14<\/sub>N<sub>2<\/sub>O<sub>2<\/sub>, MW 290,3 g\/mol) este o molecul\u0103 mic\u0103 sintetic\u0103 <strong>pan-agonist\u0103 a receptorilor estrogen-relata\u021bi<\/strong> (ERR\u03b1 \/ ERR\u03b2 \/ ERR\u03b3) dezvoltat\u0103 \u00een laboratorul Burris de la Universitatea Saint Louis. ERR sunt factori de transcrip\u021bie nucleari orfani care stimuleaz\u0103 biogeneza mitocondrial\u0103, oxidarea acizilor gra\u0219i, dezvoltarea fibrelor oxidative \u0219i programul de adaptare muscular\u0103 declan\u0219at \u00een mod normal prin exerci\u021biu \u2014 f\u0103c\u00e2nd din SLU-PP-332 un instrument de cercetare de tip <strong>\u201cmimetic al exerci\u021biului\u201d<\/strong> . Publicat \u00een Billon et al. (2023, <em>ACS Chemical Biology<\/em>) \u2014 doza unic\u0103 acut\u0103 induce un semnatur\u0103 genetic\u0103 de r\u0103spuns la exerci\u021biu aerobic \u00een mu\u0219chiul scheletic; administrarea cronic\u0103 cre\u0219te propor\u021bia fibrelor oxidative de tip IIa \u0219i \u00eembun\u0103t\u0103\u021be\u0219te capacitatea de anduran\u021b\u0103 la \u0219oareci. <em>Molecul\u0103 mic\u0103 \u2014 nu este un peptid.<\/em> Not\u0103: unele loturi de la furnizori sunt etichetate SLU-PP-322 \/ SLU-PP-332 interschimbabil \u2014 ambele se refer\u0103 la acela\u0219i pan-agonist ERR din laboratorul Burris; consulta\u021bi COA pentru identificarea specific\u0103 lotului. Pentru uz exclusiv \u00een cercetare de laborator.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Liofilizat \u226599% verificat prin HPLC SLU-PP-332 \u00b7 COA disponibil la cerere \u00b7 Ambalaj discret stabil la temperatur\u0103 \u00b7 Curierat mondial pentru aprovizionarea cu materiale de cercetare \u00b7 Peste 1.400 de <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px;\">Specifica\u021bii<\/th>\n<th style=\"padding: 8px 12px;\">Detaliu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Clas\u0103 de compu\u0219i<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Molecul\u0103 mic\u0103 sintetic\u0103 pan-agonist\u0103 a receptorilor estrogen-relata\u021bi (ERR\u03b1 \/ ERR\u03b2 \/ ERR\u03b3); agonist al receptorilor nucleari orfani; instrument de cercetare mimetic al exerci\u021biului; <em>nu este un peptid<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Denumire chimic\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">SLU-PP-332 (sinonime: SLU-PP-322 \u00een unele loturi de furnizori; pan-agonist ERR; Compusul 332 din laboratorul Burris)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Num\u0103r CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">303760-60-3 (canonic, conform MedKoo \/ MedChemExpress \/ literatur\u0103 \u0219tiin\u021bific\u0103)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Formula molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>18<\/sub>H<sub>14<\/sub>N<sub>2<\/sub>O<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Greutate molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">290,32 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Mecanism de ac\u021biune<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pan-agonist al <strong>ERR\u03b1, ERR\u03b2, ERR\u03b3<\/strong> receptorilor nucleari cu o selectivitate de ~4 ori mai mare pentru ERR\u03b1 dec\u00e2t pentru ERR\u03b3. EC<sub>50<\/sub> ERR\u03b1 ~98 nM (Billon et al. 2023). Activarea receptorilor ERR determin\u0103 transcrierea genelor \u021bint\u0103 ale PGC-1\u03b1 \u2014 biogeneza mitocondrial\u0103 (TFAM, NRF1, NRF2), \u03b2-oxidarea acizilor gra\u0219i (CPT1B, MCAD, LCAD), subunit\u0103\u021bile complexelor de fosforilare oxidativ\u0103 \u0219i lan\u021burile grele de miozin\u0103 de tip fibr\u0103 oxidativ\u0103. Efectul net imit\u0103 programul de transcrip\u021bie al adapt\u0103rii la exerci\u021biu.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Secven\u021b\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">n\/a (compus sintetic cu mas\u0103 molecular\u0103 mic\u0103 \u2014 nu este un peptid)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Form\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pudr\u0103 liofilizat\u0103 alb\u0103 p\u00e2n\u0103 la alb-g\u0103lbuie; flacoane de unic\u0103 folosin\u021b\u0103 pentru cercetare<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Puritate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificat prin HPLC, COA la cerere)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Solubilitate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">DMSO \u226550 mg\/mL; solubilitate \u00een ap\u0103 moderat\u0103 (sub-mg\/mL). Pentru lucr\u0103rile in vitro, prepara\u021bi stocuri \u00een DMSO \u0219i dilua\u021bi \u00een mediul de cultur\u0103 imediat \u00eenainte de utilizare. Pentru lucr\u0103rile in vivo, formul\u0103rile utilizeaz\u0103 de obicei sisteme de co-solven\u021bi precum DMSO\/PEG\/salin\u0103 sau similare.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Depozitare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizat: 2\u20138 \u00b0C pe termen scurt, \u221220 \u00b0C pe termen lung (\u226536 luni). DMSO reconstituit: \u221220 \u00b0C, utilizare dup\u0103 o singur\u0103 decongelare. Proteja\u021bi de lumin\u0103. Evita\u021bi ciclurile repetate de \u00eenghe\u021bare-dezghe\u021bare.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Utilizare \u00een cercetare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Doar pentru utilizare \u00een cercetare de laborator. Nu este destinat pentru uz diagnostic sau terapeutic uman sau veterinar. Nu se afl\u0103 \u00een prezent pe Lista Interzis\u0103 WADA sub numele s\u0103u specific, dar cercet\u0103torii ar trebui s\u0103 fie con\u0219tien\u021bi c\u0103 clasa mai larg\u0103 S4 (Modulatori Hormonali \u0219i Metabolici) include compu\u0219i care mimeaz\u0103 exerci\u021biul fizic, iar statutul reglementar al SLU-PP-332 poate evolua.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Mecanism de ac\u021biune \u2014 Pan-agonismul ERR determin\u0103 transcrip\u021bia adapt\u0103rii la exerci\u021biu<\/h2>\n<p>SLU-PP-332 este cel mai citat pan-agonist ERR sintetic cu mas\u0103 molecular\u0103 mic\u0103 din literatura publicat\u0103. ERR (receptorii estrogenici \u00eenrudi\u021bi \u03b1, \u03b2, \u03b3) sunt receptori nucleari orfani care au \u00een comun domeniul de legare a ADN-ului cu receptorii estrogenici, dar nu leag\u0103 estrogenul \u2014 sunt activi constitutiv \u00een absen\u021ba oric\u0103rui ligand endogen natural \u0219i sunt regula\u021bi prin legarea coactivatorilor (cel mai important fiind PGC-1\u03b1). ERR sunt principalii factori de transcrip\u021bie ai:<\/p>\n<ul>\n<li><strong>Biogenezei mitocondriale<\/strong> \u2014 control transcrip\u021bional direct al TFAM, NRF1, NRF2 \u0219i al zeci de gene de import a proteinelor mitocondriale<\/li>\n<li><strong>\u03b2-oxid\u0103rii acizilor gra\u0219i<\/strong> \u2014 inducerea CPT1B (carnitin palmitoiltransferaza 1B), MCAD, LCAD \u0219i a altor enzime de \u03b2-oxidare<\/li>\n<li><strong>Fosforilare oxidativ\u0103<\/strong> \u2014 transcrierea subun\u0103\u021bilor complexelor ETC codificate nuclear<\/li>\n<li><strong>Dezvoltarea fibrelor oxidative<\/strong> \u2014 induc\u021bia lan\u021bului greu de miozin\u0103 de tip IIa (fibre oxidative cu contrac\u021bie rapid\u0103); conversia din fibre glicolitice de tip IIb \u00een fibre oxidative de tip IIa<\/li>\n<li><strong>Adaptarea la metabolizarea glucozei<\/strong> \u2014 \u00eembun\u0103t\u0103\u021birea sensibilit\u0103\u021bii la insulin\u0103 a mu\u0219chilor scheletici \u00een modelele de \u0219oareci DIO<\/li>\n<\/ul>\n<p>Acesta este acela\u0219i program de transcriere care este activat prin adaptarea la exerci\u021bii fizice condus\u0103 de PGC-1\u03b1 \u2014 f\u0103c\u00e2nd din agonismul pan-ERR o cale farmacologic\u0103 direct\u0103 c\u0103tre fenotipul de adaptare la exerci\u021bii. Lucrarea Billon et al. (2023) <em>ACS Chemical Biology<\/em> a demonstrat c\u0103 o doz\u0103 unic\u0103 acut\u0103 de SLU-PP-332 produce o semn\u0103tur\u0103 de expresie genic\u0103 \u00een mu\u0219chiul scheletic al \u0219oarecilor care se suprapune semnificativ cu semn\u0103tura produs\u0103 de o sesiune de alergare voluntar\u0103 pe roat\u0103 \u2014 iar administrarea cronic\u0103 (50 mg\/kg\/zi IP timp de 4 s\u0103pt\u0103m\u00e2ni) cre\u0219te propor\u021bia fibrelor de tip IIa \u0219i rezisten\u021ba la alergare pe band\u0103 rulant\u0103 la \u0219oareci. Lucr\u0103rile ulterioare (Billon et al. 2024, ameliorarea sindromului metabolic) au demonstrat efecte de \u00eembun\u0103t\u0103\u021bire metabolic\u0103 la \u0219oarecii DIO, inclusiv \u00eembun\u0103t\u0103\u021birea toleran\u021bei la glucoz\u0103 \u0219i reducerea stetozei hepatice.<\/p>\n<h2>Aplica\u021bii de Cercetare Publicate<\/h2>\n<ul>\n<li><strong>Farmacologia receptorilor pan-ERR<\/strong> \u2014 micul molecule de referin\u021b\u0103 canonic\u0103 agoniste pan-ERR<\/li>\n<li><strong>Cercetare transcrip\u021bional\u0103 mimetic\u0103 a exerci\u021biului fizic<\/strong> \u2014 publicat\u0103 ca principal compus \u201cexerci\u021biu \u00eentr-o pastil\u0103\u201d al\u0103turi de <a href=\"https:\/\/medsbase.com\/ro\/aicar-acadesine\/\">AICAR<\/a>; mecanistic distinct (direct ERR vs mimetic AMPK-AMP)<\/li>\n<li><strong>Cercetare \u00een biogeneza mitocondrial\u0103<\/strong> \u2014 activator transcrip\u021bional direct al axei TFAM\/NRF1\/NRF2<\/li>\n<li><strong>Cercetare privind adaptarea mu\u0219chilor scheletici<\/strong> \u2014 induc\u021bie de fibre oxidativ tip IIa, fenotip de rezisten\u021b\u0103<\/li>\n<li><strong>Cercetare privind sindromul metabolic<\/strong> \u2014 modele murine DIO, steatoz\u0103 hepatic\u0103, sensibilitate la insulin\u0103<\/li>\n<li><strong>Farmacologia c\u0103ii PGC-1\u03b1<\/strong> \u2014 activeaz\u0103 cascada transcrip\u021bional\u0103 condus\u0103 de PGC-1\u03b1 din aval<\/li>\n<\/ul>\n<p>Pentru un context mai larg, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/aicar-acadesine\/\">AICAR<\/a> (mimetic canonic al exerci\u021biului mediat de AMPK \u2014 mecanism diferit), <a href=\"https:\/\/medsbase.com\/ro\/aod-9604\/\">AOD-9604<\/a> (peptid de cercetare pentru pierderea gr\u0103simi doar lipolitic), <a href=\"https:\/\/medsbase.com\/ro\/mots-c\/\">MOTS-c<\/a> (peptid derivat din mitocondrie), <a href=\"https:\/\/medsbase.com\/ro\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inhibitor NNMT pe axa NAD), <a href=\"https:\/\/medsbase.com\/ro\/nad\/\">NAD\u207a<\/a> (coenzim\u0103 de transport electronic).<\/p>\n<h2>Concentra\u021bii disponibile<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px;\">Putere flacon<\/th>\n<th style=\"padding: 10px;\">Dimensiuni pachet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong> \u2014 standard de cercetare; sus\u021bine cohorte de \u0219oareci DIO la 50 mg\/kg\/zi \u00d74\u20138 s\u0103pt. \u0219i farmacologia in-vitro la concentra\u021bii nM-\u00b5M<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 sau 20 flacoane<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Cum se compar\u0103 \u2014 SLU-PP-332 vs AICAR<\/h2>\n<p>SLU-PP-332 \u0219i <a href=\"https:\/\/medsbase.com\/ro\/aicar-acadesine\/\">AICAR<\/a> sunt cele mai citate substan\u021be de cercetare cu efect mimetic al exerci\u021biului fizic din acest catalog, dar ac\u021bioneaz\u0103 asupra programului de adaptare la exerci\u021biu prin c\u0103i ascendente mecanist distincte. SLU-PP-332 activeaz\u0103 direct familia ERR (factorul de transcrip\u021bie descendent pentru programul de biogenez\u0103 mitocondrial\u0103). AICAR activeaz\u0103 AMPK (kinaza senzor\u0103 de energie ascendent\u0103 care, printre multe alte efecte, stimuleaz\u0103 expresia PGC-1\u03b1 \u0219i co-activarea PGC-1\u03b1-ERR). Cele dou\u0103 substan\u021be converg astfel c\u0103tre aceea\u0219i semn\u0103tur\u0103 de expresie genic\u0103 descendent\u0103, dar o abordeaz\u0103 din puncte diferite ale cascadei de reglare.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px;\">Criteriu<\/th>\n<th style=\"padding: 10px;\">SLU-PP-332<\/th>\n<th style=\"padding: 10px;\">AICAR<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>MW<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">290,32 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">258,23 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanism de ac\u021biune<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agonist direct al receptorului nuclear ERR\u03b1\/\u03b2\/\u03b3<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Activator AMPK (prin intermediul ZMP intracelular)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Punct de interven\u021bie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Factor de transcrip\u021bie descendent<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kinaz\u0103 senzor\u0103 de energie ascendent\u0103<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Domeniul cel mai studiat<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Inducerea fibrelor oxidative de tip IIa, fenotip de rezisten\u021b\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sensibilitate la insulin\u0103, gluconeogenez\u0103 hepatic\u0103, farmacologie AMPK mai larg\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Doza tipic\u0103<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50 mg\/kg\/zi IP (\u0219oarece, protocol Billon)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mg\/kg\/zi IP (\u0219oarece)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Statut WADA<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nu este denumit \u00een prezent<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Interzis \u00een orice moment (S4.5)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Ave\u021bi nevoie de ap\u0103 BAC?<\/strong> Reconstituirea oric\u0103rui flacon liofilizat necesit\u0103 ap\u0103 bacteriostatic\u0103 steril\u0103. Combina\u021bi acest produs cu <a href=\"\/ro\/bac-water\/\"><strong>Ap\u0103 BAC (Ap\u0103 bacteriostatic\u0103)<\/strong><\/a> \u2014 flacon multidoz\u0103 de 30 mL, conservat cu 0,9% alcool benzilic, grad USP.<\/div>\n<h2>Depozitare \u0219i reconstituire<\/h2>\n<p>Flacoane liofilizate: p\u0103strare la 2\u20138 \u00b0C pe termen scurt, \u221220 \u00b0C pe termen lung. Se reconstituie \u00een DMSO la o concentra\u021bie de lucru \u226510 mg\/mL (solubilitatea \u00een ap\u0103 este limitat\u0103; DMSO este solventul preferat). Pentru studii in-vivo, se formuleaz\u0103 cu cosolven\u021bi (DMSO\/PEG-400\/salin\u0103 sau similar) imediat \u00eenainte de administrare. Stocuri DMSO se p\u0103streaz\u0103 la \u221220 \u00b0C, utilizare dup\u0103 o singur\u0103 decongelare. Proteja\u021bi de lumin\u0103. Evita\u021bi ciclurile repetate de \u00eenghe\u021bare-dezghe\u021bare.<\/p>\n<h2>\u00centreb\u0103ri frecvente<\/h2>\n<h3>\u201cSLU-PP-322\u201d este acela\u0219i lucru cu SLU-PP-332?<\/h3>\n<p>Unele loturi de la furnizori folosesc \u201cSLU-PP-322\u201d \u0219i \u201cSLU-PP-332\u201d interschimbabil pentru acela\u0219i agonist pan-ERR de la laboratorul Burris. Denumirea \u0219tiin\u021bific\u0103 canonic\u0103 este SLU-PP-332 (Billon et al. 2023, ACS Chemical Biology), cu CAS 303760-60-3. Consulta\u021bi certificatul de analiz\u0103 al lotului pentru identificarea definitiv\u0103.<\/p>\n<h3>Ce game de doze au fost utilizate \u00een publica\u021bii?<\/h3>\n<p>Protocoalele in-vivo pe \u0219oareci folosesc 50 mg\/kg\/zi IP timp de 4\u20138 s\u0103pt\u0103m\u00e2ni (protocolul canonic Billon et al.). Farmacologia in-vitro pe miotube \u0219i celule musculare primare utilizeaz\u0103 100 nM p\u00e2n\u0103 la 10 \u00b5M \u00een mediu de cre\u0219tere. EC<sub>50<\/sub> pe ERR\u03b1 este ~98 nM.<\/p>\n<h3>Cum difer\u0103 SLU-PP-332 de alte mimetici ale exerci\u021biului fizic?<\/h3>\n<p>SLU-PP-332 activeaz\u0103 direct ERR \u2014 factorii de transcrip\u021bie din aval. AICAR activeaz\u0103 AMPK (chinaza din amonte). Agoni\u0219tii PPAR\u03b4 din anii 2010 (GW501516) activeaz\u0103 un program de transcrip\u021bie diferit, dar par\u021bial suprapus. Mecanism diferit, rezultate par\u021bial suprapuse.<\/p>\n<h3>SLU-PP-332 este pe Lista de Substan\u021be Interzise WADA?<\/h3>\n<p>\u00cen prezent nu este clasificat sub numele s\u0103u specific, dar clasa mai larg\u0103 S4 (Modulatori Hormonali \u0219i Metabolici) include compu\u0219i care mimeaz\u0103 exerci\u021biul fizic. Statutul de reglementare al compusului poate evolua pe m\u0103sur\u0103 ce se acumuleaz\u0103 mai multe date de cercetare. Cercet\u0103torii care lucreaz\u0103 cu subiec\u021bi umani ar trebui s\u0103 consulte lista actual\u0103 WADA.<\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>De ce s\u0103 comanzi compu\u0219i de cercetare de la MedsBase:<\/strong> Peptide \u0219i compu\u0219i liofiliza\u021bi HPLC \u226599% \u00b7 COA disponibil la cerere \u00b7 Ambalaj discret stabil la temperatur\u0103 \u00b7 Curierat worldwide \u00b7 <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> la fiecare comand\u0103 \u00b7 Peste 1.400 de <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Al\u021bi Compu\u0219i de Cercetare Metabolic\u0103 \/ Mimetici ai Exerci\u021biului<\/h2>\n<ul>\n<li><a href=\"\/ro\/aicar-acadesine\/\"><strong>AICAR<\/strong><\/a> \u2014 Mimetic canonic al exerci\u021biului mediat de AMPK \u2014 mecanism complementar<\/li>\n<li><a href=\"\/ro\/aod-9604\/\"><strong>AOD-9604<\/strong><\/a> \u2014 Fragment C-terminal al hGH cu ac\u021biune exclusiv lipolitic\u0103<\/li>\n<li><a href=\"\/ro\/mots-c\/\"><strong>MOTS-c<\/strong><\/a> \u2014 Peptid metabolic derivat mitochondrial activator AMPK<\/li>\n<li><a href=\"\/ro\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inhibitor NNMT \u2014 economisitor de precursozi pe axa NAD<\/li>\n<li><a href=\"\/ro\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Suplimentare direct\u0103 a pool-ului de dinucleotide<\/li>\n<li><a href=\"\/ro\/bac-water\/\"><strong>Ap\u0103 BAC (Ap\u0103 bacteriostatic\u0103)<\/strong><\/a> \u2014 Necesar pentru reconstituirea oric\u0103rui flacon liofilizat \u2014 diluent steril, conservat cu 0,9% alcool benzilic<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Agonist pan sintetic cu molecule mici ale receptorilor nucleari ERR\u03b1\/\u03b2\/\u03b3<br \/>\n\u2705 Factor de transcrip\u021bie direct al biogenezei mitocondriale + induc\u021bie de fibre oxidative<br \/>\n\u2705 Compus de cercetare lider mimetic al exerci\u021biului (Billon et al. 2023, ACS Chem Biol)<br \/>\n\u2705 EC\u2085\u2080 ERR\u03b1 ~98 nM; ~4 ori mai selectiv pentru ERR\u03b1 dec\u00e2t pentru ERR\u03b3<br \/>\n\u2705 Unii furnizori eticheteaz\u0103 ca SLU-PP-322; denumirea canonic\u0103 SLU-PP-332; CAS 303760-60-3, MW 290.32<\/p>\n<p><strong>SLU-PP-332<\/strong> con\u021bine compus sintetic de cercetare pan-ERR cu molecul\u0103 mic\u0103. Nu este un peptid.<\/p>","protected":false},"featured_media":71525,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6536,6489,6535,6534,6482,6533,6532],"class_list":{"0":"post-71489","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-burris-lab-compound","8":"product_tag-exercise-mimetic","9":"product_tag-mitochondrial-biogenesis","10":"product_tag-pan-err-agonist","11":"product_tag-research-compound","12":"product_tag-slu-pp-322","13":"product_tag-slu-pp-332","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/71489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=71489"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/71525"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=71489"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=71489"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=71489"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=71489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}